York Capital Makes Strategic Growth Investment In AMC Health
York Capital Management's private equity group has made an investment in AMC Health, a telehealth and remote patient monitoring (RPM) services provider in the U.S.
“Telehealth is a crucial part of the future of healthcare, and AMC Health is a clear leader in the RPM market. AMC Health stands out for its commitment to quality, extensive experience and proven skillset delivering best-in-class connectivity to patients and caregivers and high returns on investment to payers and providers.,” said Zalmie Jacobs, Partner and Head of Private Equity at York. “We are determined to help AMC Health build on its past successes by scaling to meet customer demand, entering into new markets, forming strategic partnerships and executing on both organic growth and M&A.”
Seth Pearson, a Managing Director at York, added: “AMC Health’s appeal stems from its robust product suite incorporating advanced data analytics, machine learning, remote patient monitoring and clinical services. There is a considerable excitement around the possibilities for RPM, and AMC Health is uniquely positioned and skilled in a wide breadth of functional areas to capitalize on the opportunity. Having completed extensive market and company analysis, we are confident that our investment in AMC Health strongly aligns with our goal of backing healthcare businesses that reduce systemic costs and create opportunities for superior clinical outcomes.”
York’s investment is intended to bolster AMC Health’s continued growth in the RPM market by supporting investments in product innovation, corporate infrastructure, and sales and marketing capabilities. In connection with the investment, Jacobs and Pearson will join AMC Health’s Board of Directors.
© The Sortino Group Ltd
All Rights Reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or scanning or otherwise, except under the terms of the Copyright, Designs and Patents Act 1988 or under the terms of a licence issued by the Copyright Licensing Agency or other Reprographic Rights Organisation, without the written permission of the publisher. For more information about reprints from AlphaWeek, click here.